Evogene (EVGN) Shares Outstanding (2017 - 2025)

Evogene (EVGN) has disclosed Shares Outstanding for 9 consecutive years, with $8.7 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 33.83% to $8.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.7 million through Dec 2025, up 33.83% year-over-year, with the annual reading at $8.7 million for FY2025, 33.83% up from the prior year.
  • Shares Outstanding hit $8.7 million in Q4 2025 for Evogene, up from $6.5 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $50.6 million in Q4 2023 to a low of $6.5 million in Q4 2024.
  • Historically, Shares Outstanding has averaged $29.6 million across 5 years, with a median of $41.2 million in 2021.
  • Biggest five-year swings in Shares Outstanding: crashed 87.12% in 2024 and later skyrocketed 33.83% in 2025.
  • Year by year, Shares Outstanding stood at $41.2 million in 2021, then grew by 0.22% to $41.3 million in 2022, then increased by 22.6% to $50.6 million in 2023, then plummeted by 87.12% to $6.5 million in 2024, then surged by 33.83% to $8.7 million in 2025.
  • Business Quant data shows Shares Outstanding for EVGN at $8.7 million in Q4 2025, $6.5 million in Q4 2024, and $50.6 million in Q4 2023.